✦ LIBER ✦

Treatment of metastatic breast cancer: looking towards the future

✍ Scribed by Surabhi Amar; Vivek Roy; Edith A. Perez

Publisher: Springer US
Year: 2008
Tongue: English
Weight: 195 KB
Volume: 114
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-008-0032-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimizing the treatment of metastatic b

Optimizing the treatment of metastatic breast cancer

✍ Julie R. Gralow 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 193 KB

Herceptin in the treatment of metastatic

Herceptin in the treatment of metastatic breast cancer

✍ G. Konecny; M. Untch; M. Pegram 📂 Article 📅 1999 🏛 Springer 🌐 German ⚖ 120 KB

Treatment of metastatic breast cancer wi

Treatment of metastatic breast cancer with aminoglutethimide

✍ R. F. Asbury; R. F. Bakemeier; E. Fölsch; C. S. McCune; E. Savlov; J. M. Bennett 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 504 KB

Oral medroxyprogesterone in the treatmen

Oral medroxyprogesterone in the treatment of metastatic breast cancer

✍ Takuma Nemoto; Jashbha1 Patel; Dutzu Rosner; Thomas L. Dao 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB

In 47 postmenopausal women with evaluable breast cancer, oral medroxyprogesterone acetate (MPA) was given at a daily dose level of 400 mg. Patients with negative estrogen receptors, poor performance status , or nonresponse to previous endocrine therapy were excluded from this study. There were 25 (

Critical Analysis of the Treatment of No

Critical Analysis of the Treatment of Non-palpable Breast Cancer:Toward a Less Invasive Future?

✍ Richard P.R. Groenendijk; Han ter Horst; John G.M. Tinnemans; Rigtje F. van der 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 80 KB

Oral medroxyprogesterone acetate in the

Oral medroxyprogesterone acetate in the treatment of metastatic breast cancer

✍ Gabriel N. Hortobagyi; Aman U. Buzdar; Debra Frye; Hwee-Yong Yap; Verena Hug; Ka 📂 Article 📅 1985 🏛 Springer US 🌐 English ⚖ 464 KB